Nitrates III pp 521-527 | Cite as

Renal Changes in Low Cardiac Output Failure: Improvement with Vasodilators

  • J. A. Mantle
  • R. O. RussellJr.
  • W. N. Tauxe
  • H. P. Dustan
  • W. J. Rogers
  • C. E. Rackley
Conference paper

Abstract

The renal retention of sodium is a major clinical problem in the syndrome of congestive heart failure. Both experimental and clinical studies have demonstrated that the abnormally low urinary excretion of sodium results from a reflex vasoconstriction of the renal vascular bed [2, 3, 8]. Our earlier clinical studies of isosorbide dinitrate in patients with acute myocardial infarction and heart failure demonstrated a significant synergistic effect with furosemide in patients who were oliguric [5]. In order to investigate the mechanisms responsible for these clinical observations, we undertook a perspective study of renal function and the response to vasodilators in patients with congestive heart failure [6].

Keywords

Urea Creatinine Titration Catecholamine Cardiol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cogan JJ, Humphreys MH, Carlson CJ, Rapaport E (1980) Renal effects of nitroprusside and hydralazine in patients with congestive heart failure. Circulation 61: 316–323PubMedGoogle Scholar
  2. 2.
    Katholi RE, Oparil S, Urthaler F, James TN (1979) Mechanism of post-arrhythmic renal vasoconstriction in the anesthetized dog. J Clin Invest 64: 17–31PubMedCrossRefGoogle Scholar
  3. 3.
    Kilcoyne MM, Schmidt DH, Cannon PJ (1973) Intrarenal blood flow in congestive heart failure. Circulation 47: 786–797PubMedGoogle Scholar
  4. 4.
    Magrini F, Niarchos AP (1980) Ineffectiveness of sublingual nitroglycerine in acute left ventricular failure in the presence of massive peripheral edema. Am J Cardiol 45: 841–847PubMedCrossRefGoogle Scholar
  5. 5.
    Mantle JA, Russell RO, JR, Moraski RE, Rackley CE (1976) Isosorbide dinitrate for the relief of severe heart failure following myocardial infarction. Am J Cardiol 37: 263–268PubMedCrossRefGoogle Scholar
  6. 6.
    Mantle JA, Russell RO Jr, Tauxe WN, Dustan HP, Rogers WJ, Rackley CE (1979) Altered renal function in heart failure: Effects of vasodilators. Circulation 60: 128Google Scholar
  7. 7.
    Pierpont GL, Brown DC, Franciosa JA, Cohn JN (1980) Effect of hydralazine on renal failure in patients with congestive heart failure. Circulation 61: 323–327PubMedGoogle Scholar
  8. 8.
    Sparks HV, Kopald HH, Carriere S, Chemasky JE, Kinoshita M, Barger AC (1972) Intrarenal distribution of blood flow with chronic congestive heart failure. Am J Physiol 223: 840–846PubMedGoogle Scholar
  9. 9.
    Tauxe WN, Maher FT, Taylor WF (1971) Effective renal plasma flow: Estimation from theoretical volumes of distribution of intravenously injected I131-orthoiodohippurate. Mayo Clin Proc 46: 524–531PubMedGoogle Scholar
  10. 10.
    Walkins L Jr, Burton JA, Haber E, Cont JR, Smith FW, Barger AC (1976) The reninangiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57: 1606–1617CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • J. A. Mantle
  • R. O. RussellJr.
  • W. N. Tauxe
  • H. P. Dustan
  • W. J. Rogers
  • C. E. Rackley

There are no affiliations available

Personalised recommendations